Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.

The Journal of antimicrobial chemotherapy - 1 May 2009

Begic Damir, von Eiff Christof, Tsuji Brian T

Abstract excerpt

OBJECTIVES: Staphylococcus aureus small colony variants (SCVs) are slow-growing morphological variants associated with persistent infections. While vancomycin activity has been shown to be attenuated against SCVs of S. aureus, few data exist regarding daptomycin. The objective was to evaluate the pharmacodynamics of daptomycin against defined S. aureus mutants displaying the SCV phenotype. METHODS: Two S. aureus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Colony Count, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Daptomycin

Share to Dose-Response Relationship, Drug

Share to Microbial Sensitivity Tests

Share to Microbial Viability

Share to Models, Theoretical

Share to Staphylococcus aureus

Source

Identifiers

PMID: 19304733
DOI: 10.1093/jac/dkp069

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.PMID 19304733Read ↗

Vancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotype.Semantic proximity Read ↗

Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype.Semantic proximity Read ↗

Small colony variants (SCVs) of Staphylococcus aureus--a bacterial survival strategy.Semantic proximity Read ↗

Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides.Semantic proximity Read ↗

Staphylococcus aureus small-colony variants: Formation, infection, and treatment.Semantic proximity Read ↗

Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data.Semantic proximity Read ↗

Detection, Identification and Diagnostic Characterization of the Staphylococcal Small Colony-Variant (SCV) PhenotypeSemantic proximity Read ↗

Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.Semantic proximity Read ↗

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections.Semantic proximity Read ↗

Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians.Semantic proximity Read ↗

Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.Semantic proximity Read ↗

[Small colony variants Staphylococcus aureus].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.